| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $19.00 | 08 Nov 2023 | Direct | |
| INTERCEPT PHARMACEUTICALS, INC. | Director | Option to Purchase Common Stock | 0 | 08 Nov 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465923117113-fundaro-paolo-2023-11-08 | INTERCEPT PHARMACEUTICALS, INC. | 08 Nov 2023 | 12 | -$834,195 | 4 | Director | 13 Nov 2023, 14:47 |
| /report/000110465923064843-fundaro-paolo-2023-05-24 | INTERCEPT PHARMACEUTICALS, INC. | 24 May 2023 | 2 | $0 | 4 | Director | 25 May 2023, 20:39 |
| /report/000110465922065927-fundaro-paolo-2022-05-25 | INTERCEPT PHARMACEUTICALS, INC. | 25 May 2022 | 2 | $0 | 4 | Director, 10%+ Owner | 27 May 2022, 16:20 |
| /report/000110465921075218-fundaro-paolo-2021-05-27 | INTERCEPT PHARMACEUTICALS, INC. | 27 May 2021 | 2 | $0 | 4 | Director, 10%+ Owner | 01 Jun 2021, 19:01 |